| 1 | [SID14734027] | Active | Potency | 0.5623 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID14734027] | Active | Potency | 0.5623 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID14734027] | Active | Potency | 0.5623 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID14734027] | Active | Potency | 0.5623 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID14734027] | Active | Potency | 0.5623 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID14734027] | Active | Potency | 0.5623 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID14734027] | Active | IC50 | 1.47 | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis [AID488890, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 1.47 [uM] | | BioAssay | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis | | AID | 488890 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID14734027] | Active | AC50 | 1.917 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | AC50 | 1.917 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID14734027] | Active | IC50 | 2.13 | CHOP dose-response primary assay [AID504322, Type: confirmatory] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 2.13 [uM] | | BioAssay | CHOP dose-response primary assay | | AID | 504322 | | BioAssay type | confirmatory | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 10 | [SID14734027] | Active | Potency | 2.5119 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 11 | [SID14734027] | Active | Potency | 2.5119 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 12 | [SID14734027] | Active | Potency | 2.5119 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 13 | [SID14734027] | Active | IC50 | 2.653 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 2.653 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 14 | [SID14734027] | Active | IC50 | 2.653 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 2.653 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 15 | [SID14734027] | Active | IC50 | 2.653 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 2.653 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 16 | [SID14734027] | Active | IC50 | 2.89 | XBP1 DR counterscreen for CHOP [AID504313, Type: confirmatory] | XBP1 [Homo sapiens] [gi:47678753] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 2.89 [uM] | | BioAssay | XBP1 DR counterscreen for CHOP | | AID | 504313 | | BioAssay type | confirmatory | | Target | XBP1 [Homo sapiens] [gi:47678753] | | PubMed | | | Data Table |  |
|
| 17 | [SID14734027] | Active | EC50 | 2.918 | Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast [AID1936, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | EC50 | 2.918 [uM] | | BioAssay | Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast | | AID | 1936 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID14734027] | Active | AC50 | 4.134 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | AC50 | 4.134 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID14734027] | Active | IC50 | 4.326 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 4.326 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 20 | [SID14734027] | Active | IC50 | 4.326 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 4.326 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 21 | [SID14734027] | Active | IC50 | 4.326 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 4.326 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 22 | [SID14734027] | Active | Potency | 4.4563 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 4.4563 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 23 | [SID14734027] | Active | EC50 | 4.566 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast [AID1934, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | EC50 | 4.566 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast | | AID | 1934 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID14734027] | Active | Potency | 5.0119 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 25 | [SID14734027] | Active | Potency | 5.0119 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 26 | [SID14734027] | Active | IC50 | 6.6124 | HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1209, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 6.6124 [uM] | | BioAssay | HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1209 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 27 | [SID14734027] | Active | IC50 | 6.6124 | HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1209, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 6.6124 [uM] | | BioAssay | HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1209 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 28 | [SID14734027] | Active | Potency | 7.0795 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 29 | [SID14734027] | Active | Potency | 7.0795 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 30 | [SID14734027] | Active | Potency | 7.0795 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 31 | [SID14734027] | Active | EC50 | 7.72 | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity [AID435010, Type: confirmatory] | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | EC50 | 7.72 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity | | AID | 435010 | | BioAssay type | confirmatory | | Target | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] | | PubMed | | | Data Table |  |
|
| 32 | [SID14734027] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 33 | [SID14734027] | Active | Potency | 7.9433 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 34 | [SID14734027] | Active | Potency | 8.9125 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID14734027] | Active | Potency | 10 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 36 | [SID14734027] | Active | Potency | 11.2202 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 37 | [SID14734027] | Active | IC50 | 11.44 | A Cell Based Secondary Assay to Explore Compounds that Modulate Non-Replicating, Drug-tolerant Compounds in Replicating H37Rv TB of Mycobacterium tuberculosis [AID492952, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | IC50 | 11.44 [uM] | | BioAssay | A Cell Based Secondary Assay to Explore Compounds that Modulate Non-Replicating, Drug-tolerant Compounds in Replicating H37Rv TB of Mycobacterium tuberculosis | | AID | 492952 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID14734027] | Active | CC50 | 12.14 | A Cell Based Secondary Assay to Explore Cytotoxicity in THP-1 Cells of Compounds that Modulate Non-Replicating, Drug-tolerant Mycobacterium tuberculosis [AID489025, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | CC50 | 12.14 [uM] | | BioAssay | A Cell Based Secondary Assay to Explore Cytotoxicity in THP-1 Cells of Compounds that Modulate Non-Replicating, Drug-tolerant Mycobacterium tuberculosis | | AID | 489025 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID14734027] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID14734027] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 41 | [SID14734027] | Active | Potency | 12.5893 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 42 | [SID14734027] | Active | Potency | 13.1154 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 13.1154 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID14734027] | Active | Potency | 14.1254 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID14734027] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 45 | [SID14734027] | Active | Potency | 15.8489 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 46 | [SID14734027] | Active | Potency | 15.8489 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 47 | [SID14734027] | Active | CC50 | 20 | A Cell Based Secondary Assay to Explore Cytotoxicity in Vero E6 Cells of Compounds that Modulate Non-Replicating, Drug-tolerant Mycobacterium tuberculosis [AID492998, Type: confirmatory] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | CC50 | 20 [uM] | | BioAssay | A Cell Based Secondary Assay to Explore Cytotoxicity in Vero E6 Cells of Compounds that Modulate Non-Replicating, Drug-tolerant Mycobacterium tuberculosis | | AID | 492998 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID14734027] | Active | Potency | 28.1838 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 49 | [SID14734027] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 50 | [SID14734027] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14734027 | | CID | 5547949 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|